BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kathleen S. Wright Associates Inc. | 100 | $3,774 | 0.00% |
MARK SHEPTOFF FINANCIAL PLANNING, LLC | 100 | $3,774 | 0.00% |
D. E. Shaw & Co., Inc. | 53,900 | $2,034,186 | 0.00% |
SIMPLEX TRADING, LLC | 71,660 | $2,704 | 0.00% |
Penserra Capital Management LLC | 2,836 | $106 | 0.00% |
Allspring Global Investments Holdings, LLC | 31,318 | $1,181,941 | 0.00% |
Blue Trust, Inc. | 2,511 | $115 | 0.00% |
Sugarloaf Wealth Management, LLC | 186 | $7,020 | 0.00% |
CI INVESTMENTS INC. | 10,225 | $386 | 0.00% |
Assenagon Asset Management S.A. | 14,746 | $556,514 | 0.00% |
CITIGROUP INC | 75,000 | $2,830,500 | 0.00% |
Versant Capital Management, Inc | 154 | $5,812 | 0.00% |
FAYEZ SAROFIM & CO | 13,686 | $516,510 | 0.00% |
Cerity Partners LLC | 9,703 | $366,354 | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 37,475 | $1,414,313 | 0.00% |
Luken Investment Analytics, LLC | 74 | $2,793 | 0.00% |
RVW Wealth, LLC | 399 | $15,058 | 0.00% |
Legacy Financial Group LLC | 217 | $8,190,000 | 0.00% |
Pacifica Partners Inc. | 100 | $3,702 | 0.00% |
TIAA TRUST, NATIONAL ASSOCIATION | 16,261 | $613,690 | 0.00% |
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
External links
This page lists BAXTER INTL INC's shareholders in Q3 2023. To view BAXTER INTL INC's shareholder history, click here.